Misa Nakamura

Prof. Dr. Misa Nakamura

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2020 in International Journal of Neuroscience
Verified
Journal Article
Closed access
MNMisa Nakamura
Misa Nakamura
MIMasakazu Imaoka
Masakazu Imaoka
MTMasatoshi Takeda
Masatoshi Takeda
Bone has conventionally been considered to be a passive organ that only receives external control, but according to recent findings, it has become clear that bone is an endocrine organ that activel...

1 December 2019 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
MIMasakazu Imaoka
Masakazu Imaoka
HNHidetoshi Nakao
Hidetoshi Nakao
MNMisa Nakamura
Misa Nakamura
FTFumie Tazaki
Fumie Tazaki
MMMotohiro Maebuchi
Motohiro Maebuchi
MTMasatoshi Takeda
Masatoshi Takeda
Purpose: This study compared the effects of a combination of soy peptide supplementation and exercise with those of exercise only, on the cognitive function of elderly adults. Patients and methods: This randomized, non-blinded, controlled clinical trial included 67 participants aged 60 years or more with non-cognitive dysfunction who were divided into two groups according to the intervention method: an exercise group (Ex group, n = 36) and an exercise plus nutrition group (Ex+Nt group, n = 31). The Ex group completed a memory training activity for 15 mins and aerobic exercise for 45 mins once a week for 90 days. The Ex+Nt group completed the same training plus received soy peptide for 90 days. The Mini-Mental Status Examination score, trail-making test A/B score, skeletal muscle mass index, grip strength, gait speed, and geriatric depression scale were measured at baseline and post intervention. For comparison between the pretest and posttest measurements to determine the intervention effects, a two-way analysis of variance was performed. The significance level was set at < 5%. Results: A two-way analysis of variance revealed significant time effects on trail-making test-A score, skeletal muscle index, grip strength, and gait speed in both groups. There were significant time x group interactions for greater increase in calculation score. Conclusion: A combination of exercise and soy peptide supplementation was effective in improving a portion of cognitive function.

23 October 2011 in Bioscience, Biotechnology, and Biochemistry
Verified
Journal Article
Closed access
RKRyohei Kono
Ryohei Kono
YOYoshiharu Okuno
Yoshiharu Okuno
KIKen-Ichi Inada
Ken-Ichi Inada
ATAkihiko Tokuda
Akihiko Tokuda
HHHiroshi Hashizume
Hiroshi Hashizume
HUHirotoshi Utsunomiya
Hirotoshi Utsunomiya
Osteoporosis is a serious disease caused by decreased bone mass. There is constant matrix remodeling in bones, by which bone formation is performed by osteoblastic cells, whereas bone resorption is accomplished by osteoclast cells. We investigated the effect of a Japanese apricot (Prunus mume SIBE. et ZUCC.) extract on the proliferation and osteoblastic differentiation in pre-osteoblastic MC3T3-E1 cells. An alkaline phosphatase (ALP) activity assay, cell proliferation assay, alizarin red staining and expression analysis of osteoblastic genes were carried out to assess the proliferation and osteoblastic differentiation. The water-soluble fraction of Prunus mume (PWF) increased the ALP activity, cell proliferation and mineralization. The gene expression of osteopontin and bone morphogenetic protein-2, which are markers in the early period of osteoblastic differentiation, were significantly enhanced by the PWF treatment. PWF therefore stimulated the proliferation and osteoblastic differentiation of cells and may have potential to prevent osteoporosis.

27 September 2016 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
MNMisa Nakamura
Misa Nakamura
YKYosuke Kobashi
Yosuke Kobashi
HHHiroshi Hashizume
Hiroshi Hashizume
HOHiroyuki Oka
Hiroyuki Oka
RKRyohei Kono
Ryohei Kono
HUHirotoshi Utsunomiya
Hirotoshi Utsunomiya
A concept referred to as locomotive syndrome (LS) was proposed by the Japanese Orthopaedic Association in order to help identify middle-aged and older adults who may be at high risk of requiring healthcare services because of problems associated with locomotion. Cardiometabolic disorders, including obesity, hypertension, diabetes, and dyslipidemia, have a high prevalence worldwide. The purpose of this study was to determine the associations between LS and both body composition and cardiometabolic disorders. The study participants were 165 healthy adult Japanese women volunteers living in rural areas. LS was defined as a score ≥16 on the 25-question Geriatric Locomotive Function Scale (GLFS-25). Height, body weight, body fat percentage, body mass index (BMI), and bone status were measured. Bone status was evaluated by quantitative ultrasound (i.e., the speed of sound [SOS] of the calcaneus) and was expressed as the percent of Young Adult Mean of the SOS (%YAM). Comorbid conditions of hypertension, hyperlipidemia, and diabetes were assessed using self-report questionnaires. Twenty-nine participants (17.6 %) were classed as having LS. The LS group was older, shorter, and had a higher body fat percentage, a higher BMI, and lower bone status than the non-LS group. Multiple logistic regression analysis showed that participants with a BMI ≥23.5 kg/m2 had a significantly higher risk for LS than those with a BMI <23.5 kg/m2 (odds ratio [OR] = 3.78, p < 0.01). Furthermore, GLFS-25 scores were higher in participants with than those without hypertension, diabetes, or obesity, and significantly increased with the number of present disorders. These findings suggest that BMI may be a useful screening tool for LS. Furthermore, because hypertension and diabetes were associated with LS, the prevention of these disorders accompanied by weight management may help protect against LS.

1 September 2017 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
MNMisa Nakamura
Misa Nakamura
FTFumie Tazaki
Fumie Tazaki
KNKazuki Nomura
Kazuki Nomura
TTTaeko Takano
Taeko Takano
MHMasashi Hashimoto
Masashi Hashimoto
IKIchiro Kamei
Ichiro Kamei
In our worldwide aging society, elderly people should maintain cognitive and physical function to help avoid health problems. Dementia is a major brain disease among elderly people, and is caused by cognitive impairment. The locomotive syndrome (LS) refers to a condition in which people require healthcare services because of problems associated with locomotion. The purpose of this study was to determine the association between cognitive impairment and LS. Study participants were 142 healthy elderly female volunteers living in a rural area in Japan. Cognitive function was assessed using the Mini-Mental State Examination (MMSE). A score of ≤26 points on the MMSE was used to indicate categorically defined poor cognitive performance (cognitive impairment). The LS was defined by a score ≥16 points, and non-LS as 26 group, the ≤26 group was significantly older, had a higher percentage of body fat, and a higher GLFS-25 score. Those with LS were significantly older, had a higher body mass index, a higher percentage of body fat, and a lower MMSE score. Participants in the LS group had higher odds of cognitive impairment than those without LS [odds ratio (OR) =3.08] by logistic regression analysis adjusted for age. Furthermore, participants with GLFS-25 scores ≥6 had higher odds of cognitive impairment than those with a GLFS-25 score <6 by logistic regression analysis adjusted for both age (OR =4.44), and age and percent body fat (OR =4.12). These findings suggest that a strong relationship exists between the early stage of decreased motor function and cognitive impairment.

1 February 2003
Verified
Journal Article
Closed access
YNYasushi Nakamura
Yasushi Nakamura
HYHironao Yasuoka
Hironao Yasuoka
MTMasahiko Tsujimoto
Masahiko Tsujimoto
QYQiFeng Yang
QiFeng Yang
SIShigeru Imabun
Shigeru Imabun
KKKennichi Kakudo
Kennichi Kakudo